Description
Erythropoietin recormon is a hormone mainly produced by the kidneys that helps the body make red blood cells. In Kenya, recombinant erythropoietin medicines such as , , and are commonly used to treat anaemia, especially in patients with chronic kidney disease, cancer patients receiving chemotherapy, HIV patients on zidovudine therapy, and premature babies. These medicines help improve haemoglobin levels and may reduce the need for blood transfusions.
Recormon Erythropoietin injections may be given either under the skin or through a vein depending on the patient’s condition and the doctor’s recommendation. Treatment aims to gradually increase haemoglobin levels while avoiding rapid rises that may cause complications. Kenyan patients receiving erythropoietin therapy should have their iron levels monitored regularly because iron deficiency can reduce the effectiveness of treatment. Doctors may also prescribe iron supplements alongside therapy.
Common side effects of erythropoietin treatment include headache, high blood pressure, flu-like symptoms, skin rashes, blood clotting problems, and occasionally seizures, especially in patients with kidney disease. Blood pressure and blood counts should be monitored closely during treatment. Erythropoietin should be used cautiously in patients with uncontrolled hypertension, liver disease, seizures, or certain cancers. Any sudden loss of response to treatment should be investigated by a healthcare professional.
In Kenya, erythropoietin has also been used before surgery to reduce the need for donor blood transfusions. However, misuse of erythropoietin by athletes for performance enhancement is dangerous and strongly discouraged because it can thicken the blood and increase the risk of serious complications such as stroke or heart problems. Patients should only use erythropoietin medicines under proper medical supervision and according to prescribed doses.
Reviews
There are no reviews yet.